EAGER: Collaborative Research: Design of Inhibitors for ORF7a and ORF7b Oligomerization in COVID-19
EAGER: Collaborative Research: Design of Inhibitors for ORF7a and ORF7b Oligomerization in COVID-19
批准号:
2029895
负责人:
Bryan Berger
金额:
$15.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-15 至 2022-05-31
中文摘要
有了这一奖项,化学部门的生命过程化学项目和化学、生物工程、环境和运输系统部门的化学和生物化学工程项目将资助Bryan Berger博士(弗吉尼亚大学)和Jeffery Klauda博士(马里兰大学)研究来自covid - 19病毒的两种名为ORF7a和OR7b的蛋白质,这两种蛋白质与病毒对宿主(如人类细胞)的危害程度有关。研究将集中在这两种蛋白质如何形成更大的蛋白质复合物,进而影响病毒与受感染细胞之间的相互作用,并影响宿主的免疫反应。该研究为可用于探测病毒传播的肽的开发提供了信息。这项研究是基于计算和实验相结合的方法。伯杰博士和克劳达博士通过Addgene向科学界免费分发为本项目开发的质粒和相关协议,从而使致力于寻找当前大流行病解决方案并尽量减少未来爆发可能性的全球科学界能够迅速利用其研究成果。这项工作将为使用最先进的实验和计算方法研究关键挑战的博士后提供培训。研究结果将由该小组通过弗吉尼亚大学和马里兰大学的会议和讲习班以及通过出版物向更大的社区传播。研究人员还计划通过参与他们所在机构现有的外展项目,向学生通报和教育病毒传播和预防的可能机制。本研究项目旨在了解ORF7a与BST-2的跨膜和近膜寡聚以及ORF7b的同质寡聚的特异性基础。利用基于大肠杆菌AraC蛋白的膜蛋白二聚化细菌转录分析(AraTM和DN-AraTM分析),研究人员确定了细菌膜中蛋白质寡聚化的特定氨基酸残基和结构基元。这些知识为BST-2/ORF7a异聚物和ORF7b同聚物形成的计算模型提供了信息。反过来,计算模型用于对跨膜肽序列做出关键的新预测,这些序列可能影响涉及ORF7a和ORF7b的蛋白质-蛋白质相互作用。这些预测和肽的性质是通过合成肽库和使用AraTM, DN-AraTM和哺乳动物,基于细胞的荧光共振能量转移实验来测试的。候选序列的验证是通过基于哺乳动物细胞的BST-2功能和凋亡检测来实现的。这些研究结果可以为OR7a和ORF7b的同源和异齐聚化提供高分辨率的实验验证模型,以及可用于探索ORF7a和ORF7b在病毒体内传播中的作用的肽序列。这笔赠款是由分配给MPS和ENG的冠状病毒援助、救济和经济安全(关怀)法案补充提供的资金发放的。该奖项反映了美国国家科学基金会的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
英文摘要
With this award, the Chemistry of Life Processes Program in the Chemistry Division and the Chemical and Biochemical Engineering Program in the Chemical, Bioengineering, Environmental and Transport Systems Division are funding Dr. Bryan Berger (University of Virginia) and Dr. Jeffery Klauda (University of Maryland) to investigate two proteins named ORF7a and OR7b from the COVID19 virus that have been implicated in how harmful the virus is to its host, e.g. the human cells. The research will focus on how these two proteins form larger protein complexes that in turn affect the interactions between the virus and the infected cells and influence the immune response of the host. The research informs the development of peptides that could be used to probe the viral propagation. The research is based on the use of a combination of computational and experimental methods. Dr. Berger and Dr. Klauda distribute to the scientific community free of charge through Addgene the plasmids and associated protocols developed for this project, thus enabling the global scientific community that works on finding a solution to the current pandemic and to minimizing the possibility of future outbreaks to quickly use the outcomes of their research. This work will provide training for post-doctoral fellows working on critical challenges using state-of-the-art experimental and computational methods. The results of the research will be disseminated by the team to the greater community through conferences and workshops at University of Virginia and University of Maryland and through publications. The researchers also plan to inform and educate students on possible mechanisms of virus transmission and prevention by participation in existing outreach programs at their Institutions.This research project seeks to understand the basis of specificity for transmembrane and juxtamembrane oligomerization of ORF7a with BST-2 and for homooligomerization of ORF7b. Using bacterial transcriptional assays for membrane protein dimerization based on the E. coli AraC protein (AraTM and DN-AraTM assays), the researches determine specific amino acid residues and structural motifs responsible for the protein oligomerization in bacterial membranes. This knowledge informs computational models for formation of BST-2/ORF7a heterooligomers and ORF7b homooligomers. In turn, the computational models are used to make critical new predictions of sequences for transmembrane peptides that could influence protein-protein interactions involving ORF7a and ORF7b. These predictions and the properties of the peptides are tested by synthesizing peptide libraries and using AraTM, DN-AraTM, and mammalian, cell-based fluorescence resonance energy transfer assays. Validation of candidate sequences are achieved using mammalian cell-based assays for BST-2 function and apoptosis. The results of these studies could provide high-resolution, experimentally validated models for OR7a and ORF7b homo and heterooligomerization, as well as peptide sequences that can be used to probe the roles of ORF7a and ORF7b in viral propagation in vivo.This grant is being awarded using funds made available by the Coronavirus Aid, Relief, and Economic Security (CARES) Act supplement allocated to MPS and ENG.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collaborative Research: Harnessing synergism between biosurfactants and enzymes to enable efficient valorization of cellulose: towards a sustainable materials bioeconomy
-
批准号:2211060
-
项目类别:Standard Grant
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:Bryan Berger
-
依托单位:
CAREER: Scalable Synthesis of Designed Biosurfactants to Enhance Drug Bioavailability
-
批准号:1822580
-
项目类别:Continuing Grant
-
资助金额:$28.59万
-
财政年份:2018
-
负责人:Bryan Berger
-
依托单位:
PFI:AIR - TT: Green, Biocompatible Enzymatic Disinfectants for Broad-spectrum Inhibition and Removal of Microbial Contamination in Packaged Produce
-
批准号:1701059
-
项目类别:Standard Grant
-
资助金额:$19.96万
-
财政年份:2017
-
负责人:Bryan Berger
-
依托单位:
PFI:AIR - TT: Green, Biocompatible Enzymatic Disinfectants for Broad-spectrum Inhibition and Removal of Microbial Contamination in Packaged Produce
-
批准号:1801612
-
项目类别:Standard Grant
-
资助金额:$19.96万
-
财政年份:2017
-
负责人:Bryan Berger
-
依托单位:
SNM-IS: Scalable Biomineralization of Functional Oxide Nanoparticles and Nanostructures for Environmental and Energy Applications
-
批准号:1821389
-
项目类别:Standard Grant
-
资助金额:$149.96万
-
财政年份:2017
-
负责人:Bryan Berger
-
依托单位:
SNM-IS: Scalable Biomineralization of Functional Oxide Nanoparticles and Nanostructures for Environmental and Energy Applications
-
批准号:1727166
-
项目类别:Standard Grant
-
资助金额:$149.96万
-
财政年份:2017
-
负责人:Bryan Berger
-
依托单位:
I-Corps: Commercialization of an Enzymatic Method for Biofilm Removal
-
批准号:1612047
-
项目类别:Standard Grant
-
资助金额:$5.0万
-
财政年份:2015
-
负责人:Bryan Berger
-
依托单位:
CAREER: Scalable Synthesis of Designed Biosurfactants to Enhance Drug Bioavailability
-
批准号:1452855
-
项目类别:Continuing Grant
-
资助金额:$50.0万
-
财政年份:2015
-
负责人:Bryan Berger
-
依托单位:
BRIGE: Hierarchical Design of Membrane-Based Mechanotransduction Systems
-
批准号:1227924
-
项目类别:Standard Grant
-
资助金额:$17.5万
-
财政年份:2012
-
负责人:Bryan Berger
-
依托单位:
海外基金